论文部分内容阅读
Oncolytic adenoviruses are gaining attention as novel treatment modality for aggressive tumors.The virus Delta24-RGD (DNX-2401) is currently under phase Ⅰ/Ⅱ clinical evaluation for the treatment of glioblastoma.